ATE317687T1 - Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen - Google Patents

Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen

Info

Publication number
ATE317687T1
ATE317687T1 AT99967110T AT99967110T ATE317687T1 AT E317687 T1 ATE317687 T1 AT E317687T1 AT 99967110 T AT99967110 T AT 99967110T AT 99967110 T AT99967110 T AT 99967110T AT E317687 T1 ATE317687 T1 AT E317687T1
Authority
AT
Austria
Prior art keywords
controlled
coated
pharmaceutical formulations
formulations containing
coated particles
Prior art date
Application number
AT99967110T
Other languages
English (en)
Inventor
James D Talton
Guenther Hochhaus
Rajiv K Singh
James M Fitz-Gerald
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE317687T1 publication Critical patent/ATE317687T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/223—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating specially adapted for coating particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/24—Vacuum evaporation
    • C23C14/28—Vacuum evaporation by wave energy or particle radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99967110T 1998-11-18 1999-11-18 Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen ATE317687T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10884798P 1998-11-18 1998-11-18
US11029198P 1998-11-30 1998-11-30

Publications (1)

Publication Number Publication Date
ATE317687T1 true ATE317687T1 (de) 2006-03-15

Family

ID=26806343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967110T ATE317687T1 (de) 1998-11-18 1999-11-18 Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen

Country Status (19)

Country Link
EP (1) EP1131054B1 (de)
JP (1) JP2003516926A (de)
KR (1) KR20010082309A (de)
CN (1) CN1200693C (de)
AT (1) ATE317687T1 (de)
AU (1) AU757121B2 (de)
BR (1) BR9915462A (de)
CA (1) CA2350894C (de)
CZ (1) CZ300323B6 (de)
DE (1) DE69929904T2 (de)
ES (1) ES2257881T3 (de)
HK (1) HK1043548B (de)
HU (1) HUP0104687A3 (de)
IL (2) IL143234A0 (de)
NO (1) NO20012395L (de)
NZ (1) NZ511689A (de)
PL (1) PL349953A1 (de)
TR (1) TR200101401T2 (de)
WO (1) WO2000028969A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
AU2005201757B2 (en) * 1999-06-07 2007-04-26 Nanotherapeutics, Inc. Methods for coating particles and particles produced thereby
MXPA01012658A (es) * 1999-06-07 2003-10-15 Nanosphere Inc Metodos para recubrir particulas, y particulas producidas mediante los mismos.
US7217746B2 (en) 2000-05-19 2007-05-15 Ppg Industries Ohio, Inc. Coating compositions having a geometrically ordered array of polymeric particles and substrates coated therewith
DE60140268D1 (de) 2000-11-30 2009-12-03 Vectura Ltd Partikel zur verwendung in einer pharmazeutischen zusammensetzung
ES2474199T3 (es) * 2000-11-30 2014-07-08 Vectura Limited Composiciones farmacéuticas para inhalaci�n
WO2002049620A2 (en) * 2000-12-21 2002-06-27 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
CA2706622C (en) * 2002-08-27 2015-11-03 Hiroshi Terada Lps activation of phagocytic activity
ES2292874T3 (es) 2003-05-19 2008-03-16 Euro-Celtique S.A. Composiciones liposomales secas de pvp-yodo.
US20060251584A1 (en) * 2003-06-11 2006-11-09 Nara Machinery Co., Ltd. Drug nano-particle, method and apparatus for preparing pharmaceutical preparation using the particle
JP2006218346A (ja) * 2005-02-08 2006-08-24 Honda Motor Co Ltd 水素吸着材及びその製造方法
CA2885621C (en) * 2007-03-30 2016-01-05 Hirofumi Takeuchi Transpulmonary liposome for controlling drug arrival
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US20110014292A1 (en) * 2007-10-15 2011-01-20 Cooperative Research Centre For Asthma method of prophylaxis and agents for use therein
EP2279283A1 (de) * 2008-03-27 2011-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur herstellung eines mehrkomponentigen, polymer- und metallhaltigen schichtsystems, vorrichtung und beschichteter gegenstand
US20110104282A1 (en) * 2008-04-25 2011-05-05 Karolinska Institutet Innovations Ab New Therapy of Treatment of the Irritable Bowel Syndrome
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
WO2010044089A1 (en) * 2008-10-15 2010-04-22 Lifecare, Innovations Pvt. Ltd Drug delivery system for econazole, moxifloxacin, and rifampicin
WO2010058840A1 (ja) * 2008-11-20 2010-05-27 テルモ株式会社 リポソームからの薬物放出手段および放出性評価法
SE535381C2 (sv) 2010-02-24 2012-07-17 Plasmadvance Ab Plasmasputtringsprocess för att producera partiklar
US9609885B2 (en) * 2011-10-14 2017-04-04 Dsm Ip Assets B.V. Coating system
JP6334214B2 (ja) * 2013-03-08 2018-05-30 学校法人慶應義塾 レーザーを用いた薬剤放出方法
BR112021020096A2 (pt) * 2019-04-08 2021-12-07 Scherer Technologies Llc R P Método analítico para determinar a quantidade total de um polímero de revestimento em uma forma de dosagem
AU2021221987B2 (en) * 2020-02-19 2026-02-12 Nano Pharmasolutions, Inc. Therapeutic agent nanoparticles and methods of preparation
EP4687852A1 (de) * 2023-04-06 2026-02-11 Applied Materials, Inc. Pharmazeutische zusammensetzungen mit verbesserter auflösung
WO2025035198A1 (pt) 2023-08-17 2025-02-20 Hfm Consultoria E Holding Ltda Processo de fabricação de materiais em pó, através da pulverização controlada de átomos de um material alvo e posterior deposição em material base em pó
CN121102547B (zh) * 2025-11-17 2026-04-28 厦门市兴泉医药科技有限公司 一种智能变色的可吸收缝合线及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200669A (en) * 1978-11-22 1980-04-29 The United States Of America As Represented By The Secretary Of The Navy Laser spraying
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3541999A1 (de) * 1985-11-28 1987-06-04 Bbc Brown Boveri & Cie Verfahren und vorrichtung zur beschichtung von flaechen
WO1990002546A1 (en) * 1988-09-09 1990-03-22 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
DE4239244A1 (de) * 1992-11-21 1994-05-26 Basf Ag Retard-Form für pharmazeutische Wirkstoffe
US6025036A (en) * 1997-05-28 2000-02-15 The United States Of America As Represented By The Secretary Of The Navy Method of producing a film coating by matrix assisted pulsed laser deposition
WO1999047726A1 (en) * 1998-03-19 1999-09-23 The University Of Florida Process for depositing atomic to nanometer particle coatings on host particles

Also Published As

Publication number Publication date
NZ511689A (en) 2003-03-28
HUP0104687A3 (en) 2006-07-28
CN1348361A (zh) 2002-05-08
NO20012395L (no) 2001-07-16
BR9915462A (pt) 2001-12-11
IL143234A0 (en) 2002-04-21
NO20012395D0 (no) 2001-05-15
EP1131054B1 (de) 2006-02-15
HUP0104687A2 (en) 2002-06-29
CA2350894C (en) 2009-01-27
CZ20011747A3 (cs) 2001-10-17
TR200101401T2 (tr) 2001-11-21
ES2257881T3 (es) 2006-08-01
CA2350894A1 (en) 2000-05-25
PL349953A1 (en) 2002-10-21
WO2000028969A3 (en) 2000-11-09
JP2003516926A (ja) 2003-05-20
HK1043548A1 (en) 2002-09-20
CZ300323B6 (cs) 2009-04-22
EP1131054A2 (de) 2001-09-12
CN1200693C (zh) 2005-05-11
KR20010082309A (ko) 2001-08-29
DE69929904D1 (de) 2006-04-20
HK1043548B (zh) 2006-01-06
AU757121B2 (en) 2003-02-06
IL143234A (en) 2007-05-15
AU2345700A (en) 2000-06-05
WO2000028969A2 (en) 2000-05-25
DE69929904T2 (de) 2006-08-31

Similar Documents

Publication Publication Date Title
ATE317687T1 (de) Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen
Gulati et al. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection
Lee et al. Three-dimensional collagen/alginate hybrid scaffolds functionalized with a drug delivery system (DDS) for bone tissue regeneration
Liu et al. Electrospun PVP-core/PHBV-shell fibers to eliminate tailing off for an improved sustained release of curcumin
Gulati et al. Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays
DE69121675D1 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
Ramburrun et al. A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury
Kim et al. Porous scaffolds of gelatin–hydroxyapatite nanocomposites obtained by biomimetic approach: characterization and antibiotic drug release
Rana et al. Surface functionalization of nanobiomaterials for application in stem cell culture, tissue engineering, and regenerative medicine
Chen et al. Electrospun core–sheath nanofibers with a cellulose acetate coating for the synergistic release of zinc ion and drugs
Hadjiargyrou et al. Enhanced composite electrospun nanofiber scaffolds for use in drug delivery
BRPI0410956A (pt) pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
DE59104172D1 (de) Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren.
Sowjanya et al. Polymers used in the designing of controlled drug delivery system
Tseng et al. Nanofibers used for the delivery of analgesics
DE60325801D1 (de) Arzneistoff-Polymer beschichteter Stent mit segmentierten Homoketten-Copolymern
Nasiri et al. 3D printing of bioactive materials for drug delivery applications
Furuhashi et al. Titanium membrane layered between fluvastatin-loaded poly (lactic-co-glycolic) acid for guided bone regeneration
Ciofani et al. Characterization of an alginate-based drug delivery system for neurological applications
Miyabe et al. TiO2 nanotubes with customized diameters for local drug delivery systems
Gao et al. Dissolving PEGDA-Based Microneedles to Transdermally Deliver PDA@ Cu with Photothermal Properties for Potential Antibacterial Applications
RU2001135712A (ru) Способ нанесения покрытий на частицы и частицы, полученые этим способом
Rana et al. Investigation of cellulose acetate electrospun films for controlled drug permeability
Verma et al. Surface Modification of Biodegradable Polymers
Slepička et al. Enhancement of polymer cytocompatibility by nanostructuring of polymer surface

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties